Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122412) titled 'Exploratory Clinical Study on Umbilical Cord Mesenchymal Stem Cells for Prophylaxis Against Endothelial Injury Syndrome Following Allogeneic Hematopoietic Stem Cell Transplantation' on April 13.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Guabgzhou First People's Hospital
Condition:
Vascular Endothelial Injury Syndrome
Intervention:
Experimental group:Use human umbilical cord mesenchymal stem cell injection
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-13
Target Sample Size: Experimental group:40;Control group:20;
Countries of Recruit...